Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Nephrology  |  Family Medicine  |  Urology

Search Medical Condition
Please enter condition
Please choose location from dropdown

Benign Prostatic Hyperplasia (Enlarged Prostate) Clinical Trials

A listing of Benign Prostatic Hyperplasia (Enlarged Prostate) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (77) clinical trials

Study to investigate the effectiveness and safety of an investigational medication in the treatment of nocturia in men with BPH (prostate enlargement)

Phase N/A

This is a prospective, randomized, double-blind, vehicle-controlled, parallel 2-arm, multi-center, multinational Phase III study of the efficacy and safety of a single intraprostatic injection of PRX302 in reducing LUTS in patients with BPH.

Phase N/A

A randomized double-blinded vehicle controlled multi-center safety and efficacy study of a single intraprostatic treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.

Phase

University Urology is currently enrolling men 26 years or older who experience problems with ejaculation. You may qualify for the study if you are unable to ejaculate (cum) at all, it takes you a long time to ejaculate, you experience decrease force of ejaculation and/or decrease volume (amount) of ejaculate. ...

Phase N/A

The purpose of this study is to evaluate the efficacy and safety of NX-1207 and to see if it could be useful for men with BPH. The study treatment will consist of either an injection of NX-1207 or of a placebo into the prostate. If you end up receiving the ...

Phase

Enjoy Your Time BPH not only interferes with your health, it can disrupt your lifestyle. Common BPH symptoms are: Frequent urination with urgency, especially at night Felling bladder does not completely empty Difficulty starting Weak or intermittent stream Our physicians are conducting a research study to see if an investigational ...

Phase N/A

This study will evaluate the safety and effectiveness of different doses of OPK-88004 compared to placebo on prostate size and related lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH).

Phase N/A

A Randomized, Double-blind, Placebo-controlled Dose-ranging Study of OPK-88004 Once-a-day Dosing for 16 Weeks in Men with Signs and Symptoms of Benign Prostatic Hyperplasia

Phase

If you have benign prostatic hyperplasia (BPH) and overactive bladder (OAB), you may qualify for a research study at Advanced Clinical Research (ACR). It’s not uncommon for men diagnosed with benign prostatic hyperplasia (BPH) to also be suffering from overactive bladder symptoms (OAB). Therefore, medications for both conditions may need ...

Phase